The unusual side effects of Mounjaro and when to act on them

Why some side effects come as a surprise — and how to frame the decision

The common side effects of Mounjaro read like a gastroenterology list: nausea, loose stools, constipation, reflux. Those are the ones most people brace for. The unusual ones are trickier, because patients often wonder whether what they're experiencing is connected to the medicine at all, or just coincidence. That uncertainty is the decision point. You're not choosing whether to stop treatment (that's a prescriber's call) you're deciding whether something needs prompt attention, routine mention at your next review, or patient watching.

Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, to slow digestion and reduce appetite. That mechanism has knock-on effects beyond the stomach, which explains why some of the less expected reactions occur. The NHS medicines page for tirzepatide lists effects ranging from dizziness and headache to heart-rate changes, and the full picture is in the manufacturer's Patient Information Leaflet. Rare does not mean impossible, and knowing the pattern helps you respond proportionately rather than either dismissing something real or panicking about something minor.

If you're already on treatment and something feels off, our aftercare team is available seven days a week.

The unusual reactions patients actually ask about

A question our prescribers hear most weeks is some version of: "My hair is coming out in the shower, is that Mounjaro?" The honest answer is: probably not directly. Telogen effluvium (a temporary shift in the hair growth cycle) is a well-recognised consequence of rapid weight loss from any cause, including changes in calorie intake. It typically starts two to four months after the weight-loss begins and resolves on its own over a similar window. Protein adequacy matters here; eating enough protein while in a calorie deficit helps limit the shed. It is worth mentioning to your prescriber, but it is rarely a reason to stop.

Heart-rate increase is another one that surprises people. Tirzepatide can raise resting heart rate by a few beats per minute, particularly early in treatment. Most people don't notice; some do. A persistent or dramatic increase, palpitations, or any feeling of chest tightness is different and needs a clinical review promptly. Similarly, some patients report low mood or changes in motivation, these should always be mentioned to a prescriber rather than self-managed. Our general FAQs cover some of the practical questions patients raise between reviews.

Injection-site reactions beyond mild redness are less common but real. A hard lump that persists for more than a few days, spreading redness, or warmth at the injection site should be assessed. Rotating sites consistently (abdomen, thigh, upper arm) reduces the risk; the full Mounjaro side-effect overview includes practical injection technique notes.

When to get medical help without delay

Some signals need same-day or emergency attention. Acute pancreatitis is rare but serious: severe stomach pain that radiates to the back, with or without vomiting, should not be waited out. The MHRA underlined this in a Drug Safety Update published in January 2026, specifically flagging it as a known but infrequent risk of GLP-1 medicines. Stop taking Mounjaro and go to A&E or call 111 if you experience this.

Gallbladder problems (sharp right-sided abdominal pain, especially after eating fat) are also in the serious-but-rare category and need urgent assessment. If you want to understand what each side effect of Mounjaro involves and why it happens, that detail can help you judge how seriously to take a new symptom. Signs of a serious allergic reaction (facial swelling, difficulty breathing, widespread rash) are an emergency. And any sudden changes in vision should be assessed the same day, particularly if you have a history of diabetes-related eye complications.

For a broader picture of what the clinical trials recorded, the five most commonly reported Mounjaro side effects provides a useful reference point alongside this page.

How to report something unusual and why it matters

The Yellow Card scheme exists precisely for this: reactions that are unexpected, rare, or not yet well-characterised. Reporting at yellowcard.mhra.gov.uk takes a few minutes and contributes to post-market safety monitoring, Mounjaro carries a Black Triangle (▼) status, which means the MHRA is actively collecting data on it. You don't need to be certain a side effect is caused by the medicine to report it; suspicion is enough.

If you're weighing up whether treatment is right for you given a personal health history, the consultation is the right place to raise it. It is also worth knowing that some people experience Mounjaro with no side effects at all, and understanding what distinguishes that group can help set realistic expectations before you begin. You can explore your options and start a free consultation when you're ready. For more on what treatment involves from the beginning, the Mounjaro treatment overview covers eligibility, how the medicine works, and what the process looks like in practice. If you have questions about what side effects to watch for if you are taking Mounjaro, that guidance is available to read alongside your Patient Information Leaflet.